Business
PURE Bioscience Sets Fiscal 2019 Third Quarter and Nine-Month Financial Results Call
PURE Bioscience Sets Fiscal 2019 Third Quarter and Nine-Month Financial Results Call.
About this update from Pure Bioscience
[{"type":"text","content":"\n \n PURE Bioscience, Inc. (OTCQB: \n PURE), creator of the patented, non-toxic silver dihydrogen citrate \n (SDC) antimicrobial, announced today that on June 13, 2019 the Company \n will file its Form 10-Q shortly after the close of the market and will \n host an investor conference call that day at 1:30pm PT (4:30pm ET) to \n review fiscal 2019 third quarter and nine-month financial results.\n \n \n PURE management will also discuss the progress made to commercialize its \n two antimicrobial SDC-based food safety solutions:\n \n \n \n PURE Control® - The status of ongoing sales and marketing \n of FDA approved processing aid (direct food contact) for fresh produce.\n \n \n PURE® Hard Surface disinfectant - The status of ongoing \n commercialization in restaurant chains, processors/manufacturers, and \n the food transportation sanitization market.\n \n \n \n The Participant Dial-In Number for the conference call is 1-631-891-4304. \n Participants should dial in to the call at least five minutes before \n 1:30pm PDT (4:30pm ET) on June 13, 2019. The call can also be accessed \n “live” online at http://public.viavid.com/index.php?id=134416.\n \n \n A replay of the recorded call will be available for 90 days on the \n Company’s website (http://www.purebio.com/investors/events-presentations/). \n You can also listen to a replay of the call by dialing 1-844-512-2921 \n (international participants dial 1-412-317-6671) starting June 13, 2019, \n at 7:30pm ET through June 20, 2019 at 11:59pm ET. Please use PIN Number \n 10006753.\n \n \n About PURE Bioscience, Inc.\n \n \n PURE Bioscience, Inc. is focused on developing and commercializing our \n proprietary antimicrobial products primarily in the food safety arena -- \n providing solutions to the health and environmental challenges of \n pathogen and hygienic control. Our technology platform is based on \n patented stabilized ionic silver, and our initial products contain \n silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic \n antimicrobial agent, which offers 24-hour residual protection and \n formulates well with other compounds. As a platform technology, SDC is \n distinguished from existing products in the marketplace because of its \n superior efficacy, reduced toxicity and it mitigates bacterial \n resistance. PURE is headquartered...